Latest filing published 10 May 2023 for NVE CORP /new/, €28k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Richard W. Kramp across 4 companies, led by Synovis Life Technologies Inc, Vascular Solutions Inc and NVE CORP /new/. In total, 56 filings cover trades dated from 4 October 2006 to 9 May 2023.
Market trades split into 2 purchases (€136k) and 33 sales (€415k). The net balance comes to €280k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 8 share grants and 10 option exercises.
The record was last updated on 10 May 2023 with an option exercise (€28k) in NVE CORP /new/. The clock since the last published purchase (14 November 2014) now reads 4,361 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations